Literature DB >> 6166545

Binding of aggregated human gamma globulin by Raji cells: C1q will enhance only if it is dissociated from the C1 macromolecular complex.

U Manthei, R C Strunk.   

Abstract

The role of complement components in binding of aggregated human gamma globulin (AHG) to Raji cells was examined using the Raji cell radioimmunoassay. Incubation of AHG in normal human serum enhanced up to five-fold the binding of these complexes by Raji cells. This enhanced binding was medicated primarily by C3 receptors, however, as much as 30% of the enhanced binding was due to a heat-labile protein in serum. AHG incubated with serum-EDTA bound to Raji cells up to two-fold more than AHG incubated with unchelated serum. Since purified Clq also enhanced binding, binding of AHG after incubation with serum-EDTA was probably mediated by Clq. The enhancement effected by Clq occurred only if Clq bound first to AHG, not to the Raji cells, and if Clq bound in the absence of Clr and Cls. Speculations on a role for Clq in biological processes must consider whether the Clq in serum is available to participate. The results presented here suggest that whole serum activated by AHG contained only a small amount of Clq available for cross-linking of particles. Thus, the potential involvement of Clq in biological reactions in vivo is probably limited.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166545      PMCID: PMC1555023     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  15 in total

1.  Complement bridges between cells analysis of a possible cell-cell interaction mechanism.

Authors:  M P Dierich; B Landen
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

2.  Isolation, by partial pepsin digestion, of the three collagen-like regions present in subcomponent Clq of the first component of human complement.

Authors:  K B Reid
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

3.  Inhibition of the reconstitution of the haemolytic activity of the first component of human complement by a pepsin-derived fragment of subcomponent C1q.

Authors:  K B Reid; R B Sim; A P Faiers
Journal:  Biochem J       Date:  1977-02-01       Impact factor: 3.857

4.  Enzymatic digestion of the first component of human complement (C1q).

Authors:  H R Knobel; C Heusser; M L Rodrick; H Isliker
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

5.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

6.  The reaction of monomeric and aggregated immunoglobulins with C1.

Authors:  W Augener; H M Grey; N R Cooper; H J Müller-Eberhard
Journal:  Immunochemistry       Date:  1971-11

7.  The Raji cell radioimmune assay for detecting immune complexes in human sera.

Authors:  A N Theofilopoulos; C B Wilson; F J Dixon
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

8.  Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.

Authors:  R N Pinckard; M S Olson; P C Giclas; R Terry; J T Boyer; R A O'Rourke
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

9.  Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.

Authors:  A N Theofilopoulos; F J Dixon; V A Bokisch
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

10.  Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera.

Authors:  A N Theofilopoulos; C B Wilson; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  1 in total

1.  Metabolism of IgG in type II mixed essential cryoglobulinaemia--autologous cryoprecipitated and normal homologous IgG are incorporated into complexes and metabolized in vivo at similar rates.

Authors:  J A Schifferli; N Amos; C D Pusey; J G Sissons; D K Peters
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.